Navigation Links
Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call

CARLSBAD, Calif., May 2, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast:What:Isis Pharmaceuticals' First Quarter 2013 Financial Results and Highlights Conference CallWhen:Tuesday, May 7, 2013 at 4:30 p.m. ET / 1:30 p.m. How:Live on the Internet.  Simply log onto our Web site listed above. If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at

ABOUT ISIS PHARMACEUTICALS, INC.Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 28 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO™, in the United States for the treatment of patients with HoFH.  Genzyme is also pursuing marketing approval of KYNAMRO in other markets.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENTThis press release includes forward-looking statements regarding Isis' business and the therapeutic potential of Isis' technologies and products in development.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the commercial potential of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2012, which is on file with the SEC. Copies of this and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  Regulus Therapeutics™ is a trademark of Regulus Therapeutics Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.

SOURCE Isis Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
2. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
3. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
4. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
5. Henry Schein To Webcast First Quarter 2013 Conference Call On Tuesday, May 7 At 10:00 a.m. ET
6. Thoratec Schedules First Quarter Conference Call, Webcast
7. Volcano Corporation Schedules First Quarter Conference Call, Webcast
8. Cempra, Inc. to Report First Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on April 25, 2013
9. Amgen Announces Webcast of 2013 First Quarter Financial Results
10. HeartWare Schedules First Quarter Conference Call And Webcast
11. Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015 iCAD, ... it will feature its latest solutions for advanced ... identification of cancer at the Radiological Society of ... Chicago from November 29 to ... product advances including iReveal®, an automated breast density ...
(Date:11/30/2015)... Varian Medical Systems (NYSE: VAR ) has signed a Memorandum ... Group, the largest hospital chain in India , ... the country. The MoU was signed by Dr. K. Prabakar ... , Varian,s India managing director, in ... Varian intends to deploy its Access to Care program by leveraging ...
(Date:11/30/2015)... 2015  Precision Image Analysis Inc. (PIA), a ... announce a dramatic expansion of its capabilities as ... its ISO-9001:2008 certification for its Quality Management System, ... protocols and procedures. This expansion enables PIA to ... Core Lab services include design and optimization of ...
Breaking Medicine Technology:
(Date:11/30/2015)... York (PRWEB) , ... November 30, 2015 , ... In ... of his role as a top ophthalmologist on Long Island’s east end. During the ... teaching, innovations in surgery and treatment of glaucoma and cataracts, and how a visit ...
(Date:11/30/2015)... CASPER, Wyo. (PRWEB) , ... November 30, 2015 , ... ... is watching a family member, close friend, or animal pass away, death lives among ... tough moments. , Coming from a family of 11 children, author T Sky ...
(Date:11/30/2015)... ... 2015 , ... Sikka Software announced today that they are showcasing the Sikka ... make complex business decisions by providing the tools and information they need to grow ... 10 procedures customized by zip code. , The Sikka Software Ecosystem includes over ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... alliance around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in ... TIGR® Matrix is a long-term resorbable surgical mesh intended to support and reinforce ...
(Date:11/30/2015)... ... November 30, 2015 , ... SIMmersion’s ability to ... the medical schools of the future. To reach an audience of key visionaries ... ChangeMedEd conference in Chicago, organized by the American Medical Association. , AMA ...
Breaking Medicine News(10 mins):